PetLife Pharmaceuticals Announces Investor Analysts Research Report
August 23, 2016 14:35 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Aug. 23, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
PetLife Pharmaceuticals Rebrands all Products in Preparation for The FDA Registration Process
August 19, 2016 11:40 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Aug. 19, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for...
PetLife Pharmaceuticals, Inc. Issues Letter to Shareholders
August 16, 2016 08:00 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD , Aug. 16, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for...
PetLife Pharmaceuticals Holds First Medical Professional Investor Conference
August 01, 2016 08:30 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, Aug. 01, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for...
PetLife Pharmaceuticals Adds Seasoned Medical Professionals to the Management Team
July 25, 2016 08:00 ET
|
PetLife Pharmaceuticals, Inc.
Hancock, MD, July 25, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...